TREA

90886631 - ELLIPSES

Follow

Information

  • Trademark
  • 90886631
  • Serial Number
    90886631
  • Filing Date
    August 17, 2021
    3 years ago
  • Transaction Date
    November 26, 2024
    a month ago
  • Status Date
    November 25, 2022
    2 years ago
  • Location Date
    May 08, 2024
    7 months ago
  • Status Code
    653
  • Current Location
    TMO LAW OFFICE 127
    Employee Name
    MOSCATI, JUSTIN
  • Attorney Docket Number
    KBRN01-00004
    Attorney Name
    S. Roxanne Edwards
    Law Office Assigned Location Code
    N90
  • Owners
Information
Mark Drawing Code
4
Mark Identification
ELLIPSES
Case File Statements
  • GS0051: Pharmaceutical preparations for the treatment of cancer; veterinary preparations for the treatment of cancer; dietetic preparations for medical purposes; dietetic foods for use in clinical nutrition; food supplements; nutraceuticals for therapeutic and medical purposes; medicated food supplements; biological preparations for the treatment of cancer; anti-cancer preparations; anti-cancer drugs being preparations; compounds for treating cancer being pharmaceutical preparations; biopharmaceuticals for the treatment of cancer; anti-cancer preparations of chemical origin; anti-cancer preparations of plant origin; anti-cancer preparations of microbial origin; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations from hormones and antagonists; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; all of the aforesaid for use in oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to cancer
  • GS0421: Medical and pharmacological research services; biological research; clinical research in the field of oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and surgery in relation to cancer; medical research; providing an online network environment for research and development for drug and pharmaceutical development; providing an online network environment for the design, development and testing of drugs and pharmaceuticals; Providing scientific and technological services and research, analysis, and design relating thereto; design, development and testing of drugs and pharmaceuticals for the treatment and/or prevention of cancer; laboratory research into new drugs and pharmaceutical products; pharmaceutical drug development services; research relating into medicines; consultancy services relating to scientific and medical research; expert advice relating to drug development, being consulting services in the field of pharmaceutical research; laboratory analysis in the field of pharmaceutical research; computer hardware and software design and development in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; computer network services in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; software hosting services in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; software as a service in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; Information Technology (IT) consultancy, advisory and information services relating to a network of medical research professionals; scientific advisory services; scientific research projects and studies being scientific research and development; conducting clinical trials being scientific and medical research for others; scientific and medical clinical research for others; clinical research for cancer treatments and pharmaceuticals; providing an online network environment for clinical trials; conducting and collating a research network for treatment, cure and prevention of cancer being medical and scientific research; development of measuring and testing methods being research and development in the field of pharmaceuticals; quality control of services; evaluation of drug development services; industrial testing, namely, industrial design services; pharmaceutical product evaluation; testing of chemicals
Case File Event Statements
  • 8/20/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 10/5/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/23/2022 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/23/2022 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/23/2022 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/23/2022 - 2 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/23/2022 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/24/2022 - 2 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/25/2022 - 2 years ago
    10 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 11/25/2022 - 2 years ago
    11 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 11/25/2022 - 2 years ago
    12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 6/8/2023 - a year ago
    13 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK
  • 12/29/2023 - a year ago
    14 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK
  • 5/7/2024 - 7 months ago
    15 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 5/8/2024 - 7 months ago
    16 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK
  • 11/21/2024 - a month ago
    18 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 11/21/2024 - a month ago
    17 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 11/21/2024 - a month ago
    19 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 11/21/2024 - a month ago
    20 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 5/18/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK